Apellis Pharmaceuticals, Inc. — Form D

Apellis Pharmaceuticals, Inc. of CRESTWOOD, KY, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-17. The offering totals $60.1M, of which $20.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Robert Sinclair AdelmanDirectorCrestwood, KY
Gerald Sinclair ChanDirectorNewton, MA
Bihua Sinclair ChenDirectorCrestwood, KY
A. Sinclair DunlopDirectorBethesda, MD
Cedric FrancoisDirectorCrestwood, KY
Maha Sinclair KatabiDirectorCrestwood, KY
Alec Sinclair MachielsDirectorCrestwood, KY
Stephanie Sinclair O'BrienDirectorNewton, MA
Steven Sinclair AxonExecutive OfficerCrestwood, KY
Pascal DeschateletsExecutive OfficerCrestwood, KY
Cedric FrancoisExecutive OfficerCrestwood, KY
Daniel Sinclair GeffkenExecutive OfficerCrestwood, KY
Robert Sinclair KimExecutive OfficerCrestwood, KY
Nicole Sinclair PerryExecutive OfficerCrestwood, KY
David Sinclair WatsonExecutive OfficerCrestwood, KY
Gerald ChanDirectorMonaco, O9
Alec MachielsDirectorNew York, NY
David DarstDirectorNew York, NY
Douglas OnsiDirectorCambridge, MA
Pascal DeschateletsDirectorCrestwood, KY
Stephanie O'BrienDirectorNewton, MA
Federico Sinclair GrossiExecutive OfficerCrestwood, KY
Marie-Claude BernalDirectorWellesley, MA
Sinclair DunlopDirectorBethesda, MD
Stephen GilliesDirectorWaltham, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2016-02-08D$47.1M$47.1M
2016-01-06D$32.1M$32.1M
2015-06-09D/A$17.7M$17.7M
2014-12-17D$21.5M$6.0M
2014-08-27D/A$24.0M$17.8M
2013-08-05D$8.0M$6.0M
2012-07-25D$3.0M$693K
2011-06-20D/A$4.2M$3.0M
2011-06-01D$4.2M$1.7M
2010-05-21D$6.0M$1.7M

More